<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01654666</url>
  </required_header>
  <id_info>
    <org_study_id>RIPC2012</org_study_id>
    <nct_id>NCT01654666</nct_id>
  </id_info>
  <brief_title>Protective Effects of Long-term Remote Limb Ischemic Preconditioning For Carotid Artery Stenting</brief_title>
  <official_title>Protective Effects of Long-term Remote Limb Ischemic Preconditioning For Carotid Artery Stenting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ji Xunming</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Capital Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Remote limb ischemic preconditioning (RIPC) has neuro-protective and anti-inflammatory
      effects on ischemia- reperfusion injury. As the extent of its effect is unknown, the
      investigators will use clinical outcome, serum biochemical markers and brain magnetic
      resonance imaging (MRI) to determine whether RIPC has neuro-protective and anti-inflammatory
      effects on patients undergoing carotid artery stenting.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND: Brain ischemia and injury contributed to perioperative morbidity and mortality in
      Carotid Artery Stenting. Remote ischemic preconditioning (RIPC), brief periods of ischemia
      followed by reperfusion, can provide systemic protection for prolonged ischemia. Our previous
      study found no significant protection to the patients who received once RIPC before Carotid
      Artery Stenting. In order to investigate whether long-term RIPC before Carotid Artery
      Stenting can protect these patients from the perioperative and long-term complications, a
      prospective randomized controlled trial will be performed in the current study.

      DESIGNING: About 189 patients who are eligible for carotid artery stenting will be randomly
      assigned in 1:1:1 ratio to RIPC group, sham RIPC group and conventional Carotid Artery
      Stenting group (control). Remote limb ischemic preconditioning (RIPC) is consisted of five
      5-min cycles of bilateral arm ischemia/reperfusion, it is induced by an automated
      cuff-inflator placed on bilateral arm and inflated to 200 mmHg for 5-min followed by
      deflating the cuff for 5-min, patients in the RIPC group will do it twice a day for at least
      two weeks before carotid artery stenting. Patients in the sham RIPC group receive sham RIPC
      treatment, which is consisted of five 5-min cycles of bilateral arm ischemia/reperfusion,
      induced by an automated cuff-inflator placed on bilateral arm and inflated to 60 mmHg for
      5-min followed by deflating the cuff for 5-min, they will do it twice a day for at least two
      weeks before carotid artery stenting. Patients in the control group receive conventional
      carotid artery stenting without RIPC or sham RIPC treatment. Cerebral injury is assessed by
      serum S-100B and Neuron specific enolase (NSE), systematic inflammation is assessed by serum
      high-sensitivity C-reactive protein (hs-CRP). Post-treatment infarctions, both symptomatic
      and asymptomatic, are detected by diffusion-weighted imaging (DWI) and clinical outcomes are
      determined by cerebrovascular events, cardiac events or death.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Patients With Cerebrovascular Events, Cardiovascular Events or Death.</measure>
    <time_frame>Within six months after carotid artery stenting</time_frame>
    <description>Cerebrovascular events included ischemic stroke, transient ischemic attack (TIA), cerebral hemorrhage and hyperperfusion syndrome. Cardiovascular events included angina and myocardial infarction.Death included any reason caused death.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Participants Who Got New Diffusion-weighted Imaging (DWI) Lesions on Post-treatment Magnetic Resonance Imaging (MRI) Scans.</measure>
    <time_frame>Within 48 hours after carotid artery stenting.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum High-sensitive C-reactive Protein (Hs-CRP).</measure>
    <time_frame>Baseline, on admission, and 1 and 24 hours after carotid artery stenting.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients With Any Side Effects of Remote Ischemic Preconditioning (RIPC) Treatment.</measure>
    <time_frame>From baseline to 6 months after treatment.</time_frame>
    <description>The side effects referred to any side effects of RIPC or sham RIPC treatment, not including the sides effect of medications and CAS.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Neuron Specific Enolase (NSE) Levels.</measure>
    <time_frame>Baseline, on admission, and 1 and 24 hours after carotid artery stenting.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum S-100B Levels.</measure>
    <time_frame>Baseline, on admission, and 1 and 24 hours after carotid artery stenting.</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">189</enrollment>
  <condition>Carotid Artery Stenosis</condition>
  <arm_group>
    <arm_group_label>RIPC group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment:Patients in this group received standard medical therapy and remote ischemic preconditioning (RIPC) treatment.
Device:RIPC consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 200 mmHg for 5-min followed by deflating the cuff for 5-min,each patient in the RIPC group do it twice a day for at least two weeks before carotid artery stenting.
Procedure: Carotid Artery Stenting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment:Patients in this group received standard medical therapy alone. Procedure: Carotid Artery Stenting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham RIPC group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Treatment:Patients in this group received standard medical therapy and sham remote ischemic preconditioning treatment.
Device:Sham RIPC consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 60 mmHg for 5-min followed by deflating the cuff for 5-min, each patient in RIPC group do it twice a day for at least two weeks before carotid artery stenting.
Procedure: Carotid Artery Stenting</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Remote ischemic preconditioning</intervention_name>
    <description>Remote ischemic preconditioning consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 200 mmHg for 5-min followed by deflating the cuff for 5-min.</description>
    <arm_group_label>RIPC group</arm_group_label>
    <other_name>RIPC</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sham remote ischemic preconditioning</intervention_name>
    <description>Sham remote ischemic preconditioning consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 60 mmHg for 5-min followed by deflating the cuff for 5-min.</description>
    <arm_group_label>Sham RIPC group</arm_group_label>
    <other_name>Sham RIPC</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Carotid Artery Stenting</intervention_name>
    <description>Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
    <arm_group_label>RIPC group</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Sham RIPC group</arm_group_label>
    <other_name>CAS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Symptomatic or asymptomatic carotid artery stenosis. In symptomatic patients the
             degree of stenosis should more than 60% (Based on NASCET Criteria), in asymptomatic
             patients the degree of stenosis should more than 70% (Based on NASCET Criteria);

          2. Tolerance to any of the study medications, including clopidogrel, aspirin and statins;

          3. Can cooperate with and complete brain MRI examination;

          4. Has a negative pregnancy test within 7 days before randomization and no childbearing
             potential;

          5. Vascular ultrasound excluded intravascular thrombosis and unstable plaques in blood
             vessels of the bilateral upper limbs;

          6. No hemorrhagic tendency;

          7. Stable vital sign, normal renal and hepatic functions;

          8. Informed consent.

        Exclusion Criteria:

          1. Evolving stroke;

          2. Prior major ipsilateral stroke, if likely to confound study endpoints;

          3. Severe dementia;

          4. Hemorrhagic conversion of an ischemic stroke within the past 60 days;

          5. Chronic atrial fibrillation;

          6. Myocardial infarction within previous 30 days;

          7. Inability to understand and cooperate with study procedures or provide informed
             consent;

          8. Participating in other device or drug trial that has not completed the required
             protocol follow-up period;

          9. Any conditions that hampers proper angiographic assessment or makes percutaneous
             arterial access unsafe;

         10. High risk candidates defined as the Carotid Revascularization Endarterectomy vs.
             Stenting Trial (CREST);

         11. Any vascular, extremity soft tissue or orthopedic injury that may contraindicate
             bilateral arm ischemic preconditioning (e.g. superficial wounds and fractures of the
             arm);

         12. Blood pressure cannot be controlled lower than 200 mmHg by medications;

         13. Peripheral blood vessel disease (especially subclavian arterial and upper limb artery
             stenosis or occlusion).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xunming Ji M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Capital Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Baojun Hou</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100053</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 23, 2012</study_first_submitted>
  <study_first_submitted_qc>July 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2012</study_first_posted>
  <results_first_submitted>July 23, 2015</results_first_submitted>
  <results_first_submitted_qc>October 13, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 11, 2015</results_first_posted>
  <last_update_submitted>October 13, 2015</last_update_submitted>
  <last_update_submitted_qc>October 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Capital Medical University</investigator_affiliation>
    <investigator_full_name>Ji Xunming</investigator_full_name>
    <investigator_title>XuanWu Hospital</investigator_title>
  </responsible_party>
  <keyword>Remote ischemic preconditioning</keyword>
  <keyword>Stroke secondary prevention</keyword>
  <keyword>Carotid artery stenting</keyword>
  <keyword>Carotid stenosis</keyword>
  <keyword>Inflammation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Stenosis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Symptomatic and asymptomatic subjects with carotid artery stenosis which was more than 70% by angiography , duplex ultrasound, Computed Tomography Angiography or Magnetic Resonance Angiography (NASCET criteria), who could undergo carotid artery stenting and all follow-ups, were recruited starting from August 2012.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>RIPC Group</title>
          <description>Treatment:Patients in this group received standard medical therapy and remote ischemic preconditioning (RIPC) treatment for at least 2 weeks before carotid artery stenting.
Remote ischemic preconditioning: Remote ischemic preconditioning consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 200 mmHg for 5-min followed by deflating the cuff for 5-min.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
        </group>
        <group group_id="P2">
          <title>Control Group</title>
          <description>Treatment:Patients in this group received standard medical therapy alone for at least 2 weeks before carotid artery stenting.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
        </group>
        <group group_id="P3">
          <title>Sham RIPC Group</title>
          <description>Treatment:Patients in this group received standard medical therapy and sham RIPC treatment for at least 2 weeks before carotid artery stenting.
Sham remote ischemic preconditioning: Sham remote ischemic preconditioning consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 60 mmHg for 5-min followed by deflating the cuff for 5-min.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="63"/>
                <participants group_id="P2" count="63"/>
                <participants group_id="P3" count="63"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Primary Analysis</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="56"/>
                <participants group_id="P3" count="54"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="50"/>
                <participants group_id="P3" count="49"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="14"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Baseline Analysis Population only included participants who finished carotid artery stenting, post-treatment MRI scans and blood drawn.</population>
      <group_list>
        <group group_id="B1">
          <title>RIPC Group</title>
          <description>Treatment:Patients in this group received standard medical therapy and remote ischemic preconditioning (RIPC) treatment for at least 2 weeks before carotid artery stenting.
Remote ischemic preconditioning: Remote ischemic preconditioning consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 200 mmHg for 5-min followed by deflating the cuff for 5-min.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
        </group>
        <group group_id="B2">
          <title>Control Group</title>
          <description>Treatment:Patients in this group received standard medical therapy alone for at least 2 weeks before carotid artery stenting.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
        </group>
        <group group_id="B3">
          <title>Sham RIPC Group</title>
          <description>Treatment:Patients in this group received standard medical therapy and sham RIPC treatment for at least 2 weeks before carotid artery stenting.
Sham remote ischemic preconditioning: Sham remote ischemic preconditioning consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 60 mmHg for 5-min followed by deflating the cuff for 5-min.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="63"/>
            <count group_id="B2" value="63"/>
            <count group_id="B3" value="63"/>
            <count group_id="B4" value="189"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.49" spread="8.63"/>
                    <measurement group_id="B2" value="66.47" spread="8.54"/>
                    <measurement group_id="B3" value="65.71" spread="8.61"/>
                    <measurement group_id="B4" value="66.56" spread="8.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="44"/>
                    <measurement group_id="B4" value="135"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Han race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="63"/>
                    <measurement group_id="B3" value="63"/>
                    <measurement group_id="B4" value="189"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pre-treatment scans</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>New DWI lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No new DWI lesions</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61"/>
                    <measurement group_id="B2" value="61"/>
                    <measurement group_id="B3" value="62"/>
                    <measurement group_id="B4" value="184"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Clinical manifestation</title>
          <description>Clinical manifestation of the target carotid artery stenosis.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Symptomatic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="42"/>
                    <measurement group_id="B4" value="128"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asymptomatic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Contralateral carotid condition</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Severe stenosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Occlusion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                    <measurement group_id="B2" value="57"/>
                    <measurement group_id="B3" value="57"/>
                    <measurement group_id="B4" value="170"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Patients With Cerebrovascular Events, Cardiovascular Events or Death.</title>
        <description>Cerebrovascular events included ischemic stroke, transient ischemic attack (TIA), cerebral hemorrhage and hyperperfusion syndrome. Cardiovascular events included angina and myocardial infarction.Death included any reason caused death.</description>
        <time_frame>Within six months after carotid artery stenting</time_frame>
        <population>The analysis population only included participants who fully completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>RIPC Group</title>
            <description>Treatment:Patients in this group received standard medical therapy and remote ischemic preconditioning (RIPC) treatment for at least 2 weeks before carotid artery stenting.
Remote ischemic preconditioning: Remote ischemic preconditioning consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 200 mmHg for 5-min followed by deflating the cuff for 5-min.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Treatment:Patients in this group received standard medical therapy alone for at least 2 weeks before carotid artery stenting.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
          </group>
          <group group_id="O3">
            <title>Sham RIPC Group</title>
            <description>Treatment:Patients in this group received standard medical therapy and sham RIPC treatment for at least 2 weeks before carotid artery stenting.
Sham remote ischemic preconditioning: Sham remote ischemic preconditioning consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 60 mmHg for 5-min followed by deflating the cuff for 5-min.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Cerebrovascular Events, Cardiovascular Events or Death.</title>
          <description>Cerebrovascular events included ischemic stroke, transient ischemic attack (TIA), cerebral hemorrhage and hyperperfusion syndrome. Cardiovascular events included angina and myocardial infarction.Death included any reason caused death.</description>
          <population>The analysis population only included participants who fully completed the study.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="50"/>
                <count group_id="O3" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Ischemic stroke within 6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TIA within 6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No cerebrovascular event within 6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47"/>
                    <measurement group_id="O2" value="48"/>
                    <measurement group_id="O3" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No Cardiovascular Events</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47"/>
                    <measurement group_id="O2" value="48"/>
                    <measurement group_id="O3" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No Deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47"/>
                    <measurement group_id="O2" value="48"/>
                    <measurement group_id="O3" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Participants Who Got New Diffusion-weighted Imaging (DWI) Lesions on Post-treatment Magnetic Resonance Imaging (MRI) Scans.</title>
        <time_frame>Within 48 hours after carotid artery stenting.</time_frame>
        <population>The analysed population only included participants who finished carotid artery stenting, post-treatment MRI scans and blood drawn.</population>
        <group_list>
          <group group_id="O1">
            <title>RIPC Group</title>
            <description>Treatment:Patients in this group received standard medical therapy and remote ischemic preconditioning (RIPC) treatment for at least 2 weeks before carotid artery stenting.
Remote ischemic preconditioning: Remote ischemic preconditioning consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 200 mmHg for 5-min followed by deflating the cuff for 5-min.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Treatment:Patients in this group received standard medical therapy alone for at least 2 weeks before carotid artery stenting.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
          </group>
          <group group_id="O3">
            <title>Sham RIPC Group</title>
            <description>Treatment:Patients in this group received standard medical therapy and sham RIPC treatment for at least 2 weeks before carotid artery stenting.
Sham remote ischemic preconditioning: Sham remote ischemic preconditioning consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 60 mmHg for 5-min followed by deflating the cuff for 5-min.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Participants Who Got New Diffusion-weighted Imaging (DWI) Lesions on Post-treatment Magnetic Resonance Imaging (MRI) Scans.</title>
          <population>The analysed population only included participants who finished carotid artery stenting, post-treatment MRI scans and blood drawn.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="56"/>
                <count group_id="O3" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>With new lesions on post-treatment scans</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Without new lesions on post-treatment scans</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                    <measurement group_id="O2" value="30"/>
                    <measurement group_id="O3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum High-sensitive C-reactive Protein (Hs-CRP).</title>
        <time_frame>Baseline, on admission, and 1 and 24 hours after carotid artery stenting.</time_frame>
        <population>The analysed population only included participants who finished carotid artery stenting, post-treatment MRI scans and blood drawn.</population>
        <group_list>
          <group group_id="O1">
            <title>RIPC Group</title>
            <description>Treatment:Patients in this group received standard medical therapy and remote ischemic preconditioning (RIPC) treatment for at least 2 weeks before carotid artery stenting.
Remote ischemic preconditioning: Remote ischemic preconditioning consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 200 mmHg for 5-min followed by deflating the cuff for 5-min.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Treatment:Patients in this group received standard medical therapy alone for at least 2 weeks before carotid artery stenting.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
          </group>
          <group group_id="O3">
            <title>Sham RIPC Group</title>
            <description>Treatment:Patients in this group received standard medical therapy and sham RIPC treatment for at least 2 weeks before carotid artery stenting.
Sham remote ischemic preconditioning: Sham remote ischemic preconditioning consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 60 mmHg for 5-min followed by deflating the cuff for 5-min.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Serum High-sensitive C-reactive Protein (Hs-CRP).</title>
          <population>The analysed population only included participants who finished carotid artery stenting, post-treatment MRI scans and blood drawn.</population>
          <units>mg/L</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="56"/>
                <count group_id="O3" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.23" lower_limit="0.69" upper_limit="4.73"/>
                    <measurement group_id="O2" value="1.22" lower_limit="0.76" upper_limit="4.67"/>
                    <measurement group_id="O3" value="1.37" lower_limit="0.81" upper_limit="3.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>On admission</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.99" lower_limit="0.59" upper_limit="3.51"/>
                    <measurement group_id="O2" value="1.09" lower_limit="0.85" upper_limit="2.56"/>
                    <measurement group_id="O3" value="1.35" lower_limit="0.57" upper_limit="3.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour after CAS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.31" lower_limit="0.61" upper_limit="2.93"/>
                    <measurement group_id="O2" value="1.46" lower_limit="0.78" upper_limit="3.60"/>
                    <measurement group_id="O3" value="1.55" lower_limit="1.09" upper_limit="4.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours after CAS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.09" lower_limit="2.29" upper_limit="11.54"/>
                    <measurement group_id="O2" value="7.90" lower_limit="4.63" upper_limit="13.90"/>
                    <measurement group_id="O3" value="6.90" lower_limit="3.75" upper_limit="9.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patients With Any Side Effects of Remote Ischemic Preconditioning (RIPC) Treatment.</title>
        <description>The side effects referred to any side effects of RIPC or sham RIPC treatment, not including the sides effect of medications and CAS.</description>
        <time_frame>From baseline to 6 months after treatment.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RIPC Group</title>
            <description>Treatment:Patients in this group received standard medical therapy and remote ischemic preconditioning (RIPC) treatment for at least 2 weeks before carotid artery stenting.
Remote ischemic preconditioning: Remote ischemic preconditioning consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 200 mmHg for 5-min followed by deflating the cuff for 5-min.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Treatment:Patients in this group received standard medical therapy alone for at least 2 weeks before carotid artery stenting.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
          </group>
          <group group_id="O3">
            <title>Sham RIPC Group</title>
            <description>Treatment:Patients in this group received standard medical therapy and sham RIPC treatment for at least 2 weeks before carotid artery stenting.
Sham remote ischemic preconditioning: Sham remote ischemic preconditioning consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 60 mmHg for 5-min followed by deflating the cuff for 5-min.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patients With Any Side Effects of Remote Ischemic Preconditioning (RIPC) Treatment.</title>
          <description>The side effects referred to any side effects of RIPC or sham RIPC treatment, not including the sides effect of medications and CAS.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="50"/>
                <count group_id="O3" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Neuron Specific Enolase (NSE) Levels.</title>
        <time_frame>Baseline, on admission, and 1 and 24 hours after carotid artery stenting.</time_frame>
        <population>The analysed population only included participants who finished carotid artery stenting, post-treatment MRI scans and blood drawn.</population>
        <group_list>
          <group group_id="O1">
            <title>RIPC Group</title>
            <description>Treatment:Patients in this group received standard medical therapy and remote ischemic preconditioning (RIPC) treatment for at least 2 weeks before carotid artery stenting.
Remote ischemic preconditioning: Remote ischemic preconditioning consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 200 mmHg for 5-min followed by deflating the cuff for 5-min.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Treatment:Patients in this group received standard medical therapy alone for at least 2 weeks before carotid artery stenting.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
          </group>
          <group group_id="O3">
            <title>Sham RIPC Group</title>
            <description>Treatment:Patients in this group received standard medical therapy and sham RIPC treatment for at least 2 weeks before carotid artery stenting.
Sham remote ischemic preconditioning: Sham remote ischemic preconditioning consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 60 mmHg for 5-min followed by deflating the cuff for 5-min.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Neuron Specific Enolase (NSE) Levels.</title>
          <population>The analysed population only included participants who finished carotid artery stenting, post-treatment MRI scans and blood drawn.</population>
          <units>ng/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="56"/>
                <count group_id="O3" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.83" spread="3.07"/>
                    <measurement group_id="O2" value="12.51" spread="2.92"/>
                    <measurement group_id="O3" value="12.12" spread="2.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>On admission</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.63" spread="3.77"/>
                    <measurement group_id="O2" value="12.85" spread="3.59"/>
                    <measurement group_id="O3" value="12.56" spread="2.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour after CAS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.00" spread="2.85"/>
                    <measurement group_id="O2" value="13.18" spread="3.98"/>
                    <measurement group_id="O3" value="13.01" spread="4.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours after CAS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.65" spread="2.78"/>
                    <measurement group_id="O2" value="12.97" spread="4.28"/>
                    <measurement group_id="O3" value="12.77" spread="3.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum S-100B Levels.</title>
        <time_frame>Baseline, on admission, and 1 and 24 hours after carotid artery stenting.</time_frame>
        <population>The analysed population only included participants who finished carotid artery stenting, post-treatment MRI scans and blood drawn.</population>
        <group_list>
          <group group_id="O1">
            <title>RIPC Group</title>
            <description>Treatment:Patients in this group received standard medical therapy and remote ischemic preconditioning (RIPC) treatment for at least 2 weeks before carotid artery stenting.
Remote ischemic preconditioning: Remote ischemic preconditioning consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 200 mmHg for 5-min followed by deflating the cuff for 5-min.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Treatment:Patients in this group received standard medical therapy alone for at least 2 weeks before carotid artery stenting.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
          </group>
          <group group_id="O3">
            <title>Sham RIPC Group</title>
            <description>Treatment:Patients in this group received standard medical therapy and sham RIPC treatment for at least 2 weeks before carotid artery stenting.
Sham remote ischemic preconditioning: Sham remote ischemic preconditioning consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 60 mmHg for 5-min followed by deflating the cuff for 5-min.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
          </group>
        </group_list>
        <measure>
          <title>Serum S-100B Levels.</title>
          <population>The analysed population only included participants who finished carotid artery stenting, post-treatment MRI scans and blood drawn.</population>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="56"/>
                <count group_id="O3" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.64" spread="15.74"/>
                    <measurement group_id="O2" value="50.14" spread="17.04"/>
                    <measurement group_id="O3" value="50.42" spread="13.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>On admission</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.70" spread="16.25"/>
                    <measurement group_id="O2" value="50.75" spread="16.79"/>
                    <measurement group_id="O3" value="51.24" spread="13.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour after CAS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.99" spread="20.21"/>
                    <measurement group_id="O2" value="51.19" spread="22.40"/>
                    <measurement group_id="O3" value="51.79" spread="19.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours after CAS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.40" spread="16.16"/>
                    <measurement group_id="O2" value="52.94" spread="24.34"/>
                    <measurement group_id="O3" value="52.02" spread="19.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Through 6 months post carotid artery stenting.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>RIPC Group</title>
          <description>Treatment:Patients in this group received standard medical therapy and remote ischemic preconditioning (RIPC) treatment for at least 2 weeks before carotid artery stenting.
Remote ischemic preconditioning: Remote ischemic preconditioning consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 200 mmHg for 5-min followed by deflating the cuff for 5-min.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
        </group>
        <group group_id="E2">
          <title>Control Group</title>
          <description>Treatment:Patients in this group received standard medical therapy alone for at least 2 weeks before carotid artery stenting.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
        </group>
        <group group_id="E3">
          <title>Sham RIPC Group</title>
          <description>Treatment:Patients in this group received standard medical therapy and sham RIPC treatment for at least 2 weeks before carotid artery stenting.
Sham remote ischemic preconditioning: Sham remote ischemic preconditioning consisted of five 5-min cycles of bilateral arm ischemia/reperfusion, which is induced by an automated cuff-inflator placed on bilateral arm and inflated to 60 mmHg for 5-min followed by deflating the cuff for 5-min.
Carotid Artery Stenting: Carotid Artery Stenting is an invasive therapy of carotid artery stenosis.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="56"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperperfusion Syndrome</sub_title>
                <description>The hyperperfusion syndrome is characterized by headache, focal motor seizures and intracerebral hemorrhage, it can be evidenced by head Computed Tomography, Magnetic Resonance Imaging, Electroencephalogram.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="56"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>Symptomatic Ischemic Stroke</sub_title>
                <description>Symptomatic ischemic stroke is defined as an acute neurological event lasting over 24 hours with focal signs and symptoms</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="56"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>Transient Ischemic Attack</sub_title>
                <description>Transient ischemic attack (TIA) is a brief episode (&lt;24 hours) of neurologic dysfunction resulting from focal temporary cerebral ischemia not associated with cerebral infarction.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="52"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="56"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="56"/>
                <counts group_id="E3" subjects_affected="23" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>At least one new lesion</sub_title>
                <description>Number of participant with new DWI lesions on post-treatment MRI scans</description>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="52"/>
                <counts group_id="E2" events="26" subjects_affected="26" subjects_at_risk="56"/>
                <counts group_id="E3" events="23" subjects_affected="23" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Xunming Ji, M.D.,Ph.D</name_or_title>
      <organization>XuanWu Hospital, Capital Medical University</organization>
      <phone>8683198127</phone>
      <email>jixunming@vip.163.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

